Literature DB >> 18166779

Tumor lysis syndrome: current perspective.

Jessica Hochberg, Mitchell S Cairo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18166779     DOI： 10.3324/haematol.12327

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  34 in total

1.  Tumor Lysis Syndrome in Multiple Myeloma: An Increasingly Recognized Risk-A Report of Seven Cases.

Authors:  Abhijai Singh; Shweta Gupta; Barbara Yim; Romy Thekkekara
Journal:  Indian J Hematol Blood Transfus       Date:  2016-10-03       Impact factor: 0.900

2.  A randomized trial of a single-dose rasburicase versus five-daily doses in patients at risk for tumor lysis syndrome.

Authors:  S Vadhan-Raj; L E Fayad; M A Fanale; B Pro; A Rodriguez; F B Hagemeister; C E Bueso-Ramos; X Zhou; P W McLaughlin; N Fowler; J Shah; R Z Orlowski; F Samaniego; M Wang; J E Cortes; A Younes; L W Kwak; N J Sarlis; J E Romaguera
Journal:  Ann Oncol       Date:  2011-10-19       Impact factor: 32.976

3.  Spontaneous tumour lysis syndrome associated with contrast dye iohexol use in mantle cell lymphoma.

Authors:  Seongseok Yun; Nicole D Vincelette; Tuan Phan; Faiz Anwer
Journal:  BMJ Case Rep       Date:  2014-07-15

Review 4.  Tumor lysis syndrome and primary hepatic malignancy: case presentation and review of the literature.

Authors:  Sean P Zivin; Youssef Elias; Charles E Ray
Journal:  Semin Intervent Radiol       Date:  2015-03       Impact factor: 1.513

5.  Analysis of the incidence of tumor lysis syndrome in patients with hematological malignancies treated with rasburicase.

Authors:  Eiseki Usami; Michio Kimura; Mina Iwai; Hitomi Teramachi; Tomoaki Yoshimura
Journal:  Mol Clin Oncol       Date:  2017-04-28

6.  Spontaneous tumour lysis syndrome secondary to the transformation of chronic myelomonocytic leukaemia into acute myeloid leukaemia.

Authors:  Alexander Langridge; Kathryn Musgrave; Yogesh Upadhye
Journal:  BMJ Case Rep       Date:  2016-03-09

7.  Effect of Vitamin D Supplementation on Delayed Hyperphosphatemia in Pediatric Acute Lymphoblastic Leukemia Patients During Induction Chemotherapy.

Authors:  Anthony W Lee; Gale L Romanowski; James A Proudfoot; Dennis J Kuo
Journal:  J Pediatr Pharmacol Ther       Date:  2017 Mar-Apr

8.  Postoperative hyperphosphatemia significantly associates with adverse survival in colorectal cancer patients.

Authors:  Zhong Ye; Juan P Palazzo; Liz Lin; Yinzhi Lai; Fran Guiles; Ronald E Myers; Jin Han; Jinliang Xing; Hushan Yang
Journal:  J Gastroenterol Hepatol       Date:  2013-09       Impact factor: 4.029

Review 9.  NK/T-cell lymphomas in children.

Authors:  Catherine Lai; Kieron Dunleavy
Journal:  Best Pract Res Clin Haematol       Date:  2013-05-23       Impact factor: 3.020

10.  Acute renal failure and type B lactic acidosis as first manifestation of extranodal T-cell lymphoblastic lymphoma.

Authors:  Seongseok Yun; Courtney N Walker; Nicole D Vincelette; Faiz Anwer
Journal:  BMJ Case Rep       Date:  2014-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.